INE987B01026
INE987B01026
NATCO PHARMA LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 145.25B EUR | 166.79B EUR | 174.49B EUR | 161.72B EUR |
Enterprise Value | 127.23B EUR | 166.79B EUR | 179.64B EUR | 161.72B EUR |
Valuation Multiples | ||||
Trailing P/E | 12.46x | 14.58x | 12.3x | 14.05x |
Forward P/E | 16.67x | -- | -- | -- |
Price to Sales | 4.17x | 4.79x | 4.28x | 4.84x |
Price to Book | 1.53x | -- | 1.89x | -- |
EV/Revenue | 3.65x | 4.79x | 4.4x | 4.84x |
EV/EBITDA | 11.89x | 12.38x | 10.36x | 10.58x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |